Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Military Personnel | 15 | 2025 | 94 | 6.810 |
Why?
|
| Petroleum Pollution | 8 | 2025 | 12 | 4.440 |
Why?
|
| Occupational Exposure | 18 | 2025 | 88 | 3.760 |
Why?
|
| Environmental Pollutants | 6 | 2024 | 54 | 2.950 |
Why?
|
| Thyroid Neoplasms | 5 | 2024 | 433 | 1.920 |
Why?
|
| Petroleum | 5 | 2021 | 13 | 1.810 |
Why?
|
| Polychlorinated Biphenyls | 4 | 2024 | 8 | 1.810 |
Why?
|
| Emergency Responders | 3 | 2018 | 7 | 1.620 |
Why?
|
| Water Pollutants, Chemical | 4 | 2021 | 139 | 1.400 |
Why?
|
| DNA Methylation | 5 | 2016 | 677 | 1.360 |
Why?
|
| Internal Medicine | 4 | 2024 | 366 | 1.240 |
Why?
|
| Internship and Residency | 4 | 2024 | 1084 | 1.170 |
Why?
|
| Early Detection of Cancer | 3 | 2023 | 469 | 1.090 |
Why?
|
| Occupational Diseases | 4 | 2017 | 55 | 1.080 |
Why?
|
| Carcinoma, Papillary | 2 | 2018 | 157 | 1.000 |
Why?
|
| Occupational Injuries | 1 | 2025 | 3 | 0.940 |
Why?
|
| Ships | 3 | 2017 | 5 | 0.930 |
Why?
|
| Curriculum | 6 | 2024 | 583 | 0.910 |
Why?
|
| Hydrocarbons, Chlorinated | 2 | 2019 | 4 | 0.900 |
Why?
|
| Pesticides | 7 | 2016 | 29 | 0.880 |
Why?
|
| Case-Control Studies | 13 | 2024 | 1901 | 0.860 |
Why?
|
| Health Equity | 2 | 2023 | 98 | 0.860 |
Why?
|
| Endocrine Disruptors | 1 | 2024 | 28 | 0.850 |
Why?
|
| Agricultural Workers' Diseases | 9 | 2015 | 18 | 0.840 |
Why?
|
| Students, Health Occupations | 1 | 2023 | 5 | 0.830 |
Why?
|
| Humans | 67 | 2025 | 92339 | 0.780 |
Why?
|
| Sexual Health | 1 | 2022 | 19 | 0.780 |
Why?
|
| Cross-Sectional Studies | 7 | 2025 | 1774 | 0.760 |
Why?
|
| Adult | 36 | 2025 | 27538 | 0.750 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2012 | 14 | 0.750 |
Why?
|
| Vaginal Smears | 1 | 2021 | 70 | 0.730 |
Why?
|
| Respiratory Tract Diseases | 3 | 2018 | 45 | 0.720 |
Why?
|
| Gulf of Mexico | 4 | 2025 | 6 | 0.720 |
Why?
|
| Female | 43 | 2025 | 47893 | 0.710 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 102 | 0.710 |
Why?
|
| Students, Medical | 2 | 2023 | 433 | 0.700 |
Why?
|
| Middle Aged | 37 | 2025 | 27043 | 0.690 |
Why?
|
| Insecticides | 5 | 2010 | 27 | 0.680 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2020 | 3 | 0.670 |
Why?
|
| Polybrominated Biphenyls | 1 | 2020 | 5 | 0.670 |
Why?
|
| Education, Medical | 1 | 2023 | 246 | 0.660 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2019 | 6 | 0.660 |
Why?
|
| Herbicides | 7 | 2015 | 36 | 0.660 |
Why?
|
| Breast Density | 1 | 2019 | 35 | 0.640 |
Why?
|
| Education, Medical, Graduate | 3 | 2024 | 411 | 0.640 |
Why?
|
| Stomach Neoplasms | 3 | 2011 | 296 | 0.630 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 3054 | 0.620 |
Why?
|
| Interleukin-16 | 1 | 2018 | 7 | 0.610 |
Why?
|
| Male | 39 | 2025 | 43927 | 0.600 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 307 | 0.590 |
Why?
|
| DNA | 4 | 2016 | 1314 | 0.590 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 274 | 0.590 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 1191 | 0.590 |
Why?
|
| Mortality | 3 | 2009 | 150 | 0.580 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 159 | 0.580 |
Why?
|
| Women's Health | 3 | 2024 | 105 | 0.580 |
Why?
|
| Interleukin-15 | 1 | 2018 | 76 | 0.580 |
Why?
|
| Hot Temperature | 1 | 2018 | 213 | 0.570 |
Why?
|
| Prospective Studies | 18 | 2021 | 4471 | 0.550 |
Why?
|
| Environmental Exposure | 5 | 2021 | 340 | 0.540 |
Why?
|
| Construction Industry | 1 | 2017 | 1 | 0.540 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2017 | 2 | 0.540 |
Why?
|
| Farmers | 1 | 2016 | 5 | 0.540 |
Why?
|
| Air Pollutants, Occupational | 1 | 2016 | 6 | 0.540 |
Why?
|
| Brain Neoplasms | 2 | 2024 | 806 | 0.530 |
Why?
|
| Ostomy | 1 | 2017 | 15 | 0.530 |
Why?
|
| North Carolina | 15 | 2016 | 52 | 0.530 |
Why?
|
| Huntington Disease | 1 | 2017 | 34 | 0.530 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 163 | 0.520 |
Why?
|
| Neoplasms | 14 | 2015 | 3124 | 0.520 |
Why?
|
| Iowa | 14 | 2016 | 35 | 0.520 |
Why?
|
| Carcinogens | 5 | 2015 | 112 | 0.520 |
Why?
|
| Occupational Health | 1 | 2016 | 36 | 0.520 |
Why?
|
| Patient Participation | 1 | 2018 | 227 | 0.500 |
Why?
|
| Glioma | 1 | 2018 | 304 | 0.500 |
Why?
|
| Thyrotropin | 1 | 2017 | 302 | 0.490 |
Why?
|
| Colonoscopy | 1 | 2017 | 300 | 0.480 |
Why?
|
| Health Behavior | 1 | 2017 | 185 | 0.480 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 972 | 0.460 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1072 | 0.450 |
Why?
|
| Cyclonic Storms | 1 | 2014 | 4 | 0.450 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 166 | 0.440 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 1771 | 0.430 |
Why?
|
| Young Adult | 8 | 2025 | 6630 | 0.430 |
Why?
|
| Cohort Studies | 13 | 2023 | 2978 | 0.430 |
Why?
|
| Receptors, Progesterone | 2 | 2005 | 179 | 0.430 |
Why?
|
| Mesothelioma | 1 | 2017 | 327 | 0.420 |
Why?
|
| Receptors, Estrogen | 2 | 2005 | 401 | 0.400 |
Why?
|
| United States | 10 | 2025 | 7348 | 0.390 |
Why?
|
| Alu Elements | 1 | 2012 | 16 | 0.380 |
Why?
|
| Acetamides | 2 | 2015 | 27 | 0.380 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 155 | 0.350 |
Why?
|
| Poisson Distribution | 7 | 2018 | 48 | 0.340 |
Why?
|
| Incidence | 10 | 2021 | 1661 | 0.330 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 120 | 0.330 |
Why?
|
| Atrazine | 2 | 2011 | 2 | 0.320 |
Why?
|
| Risk Assessment | 8 | 2023 | 2368 | 0.320 |
Why?
|
| Surveys and Questionnaires | 10 | 2022 | 2729 | 0.320 |
Why?
|
| Military Medicine | 1 | 2009 | 22 | 0.310 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 1041 | 0.310 |
Why?
|
| Longevity | 1 | 2009 | 58 | 0.310 |
Why?
|
| Odds Ratio | 7 | 2012 | 694 | 0.310 |
Why?
|
| Permethrin | 1 | 2008 | 9 | 0.310 |
Why?
|
| Risk Factors | 9 | 2025 | 5706 | 0.300 |
Why?
|
| Organic Chemicals | 1 | 2008 | 36 | 0.290 |
Why?
|
| Logistic Models | 4 | 2020 | 1239 | 0.280 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 2395 | 0.280 |
Why?
|
| Topography, Medical | 1 | 2006 | 4 | 0.250 |
Why?
|
| Agriculture | 5 | 2010 | 41 | 0.250 |
Why?
|
| Age Factors | 5 | 2021 | 1903 | 0.240 |
Why?
|
| Adipose Tissue | 2 | 2005 | 267 | 0.240 |
Why?
|
| Pesticide Residues | 1 | 2005 | 2 | 0.240 |
Why?
|
| Aged | 17 | 2019 | 19951 | 0.240 |
Why?
|
| Risk | 2 | 2021 | 661 | 0.240 |
Why?
|
| Accidental Falls | 1 | 2025 | 49 | 0.230 |
Why?
|
| Wounds, Penetrating | 1 | 2025 | 56 | 0.220 |
Why?
|
| Competency-Based Education | 1 | 2024 | 38 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 876 | 0.210 |
Why?
|
| Cadherins | 2 | 2016 | 165 | 0.210 |
Why?
|
| Meningioma | 1 | 2024 | 66 | 0.210 |
Why?
|
| Meningeal Neoplasms | 1 | 2024 | 71 | 0.210 |
Why?
|
| General Practitioners | 1 | 2023 | 11 | 0.210 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 3776 | 0.200 |
Why?
|
| Veterans | 1 | 2024 | 89 | 0.200 |
Why?
|
| Anxiety Disorders | 1 | 2024 | 156 | 0.200 |
Why?
|
| Drama | 1 | 2022 | 7 | 0.200 |
Why?
|
| Antigens, CD | 2 | 2016 | 474 | 0.190 |
Why?
|
| Primary Prevention | 1 | 2023 | 82 | 0.190 |
Why?
|
| Registries | 5 | 2019 | 903 | 0.190 |
Why?
|
| Self Report | 2 | 2024 | 307 | 0.190 |
Why?
|
| American Cancer Society | 1 | 2021 | 13 | 0.190 |
Why?
|
| Prevalence | 2 | 2025 | 1298 | 0.190 |
Why?
|
| Confidence Intervals | 5 | 2011 | 219 | 0.190 |
Why?
|
| Intimate Partner Violence | 1 | 2021 | 28 | 0.180 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2021 | 34 | 0.180 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 2 | 2011 | 4 | 0.180 |
Why?
|
| Glioblastoma | 1 | 2024 | 275 | 0.180 |
Why?
|
| Patient Care | 1 | 2022 | 102 | 0.180 |
Why?
|
| Papillomavirus Vaccines | 1 | 2021 | 57 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2011 | 105 | 0.170 |
Why?
|
| Alabama | 1 | 2019 | 10 | 0.170 |
Why?
|
| Blast Injuries | 1 | 2020 | 12 | 0.160 |
Why?
|
| Age Distribution | 2 | 2018 | 206 | 0.160 |
Why?
|
| Sexual Behavior | 1 | 2022 | 320 | 0.160 |
Why?
|
| Guideline Adherence | 1 | 2021 | 239 | 0.160 |
Why?
|
| Contraception | 1 | 2020 | 99 | 0.160 |
Why?
|
| Communication | 1 | 2023 | 462 | 0.160 |
Why?
|
| Personal Protective Equipment | 1 | 2019 | 36 | 0.160 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 31 | 0.160 |
Why?
|
| Counseling | 1 | 2020 | 171 | 0.150 |
Why?
|
| Headache | 1 | 2019 | 79 | 0.150 |
Why?
|
| Baltimore | 2 | 2017 | 41 | 0.150 |
Why?
|
| Fungicides, Industrial | 2 | 2008 | 2 | 0.150 |
Why?
|
| Primary Health Care | 1 | 2022 | 362 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2024 | 807 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 429 | 0.150 |
Why?
|
| Pennsylvania | 1 | 2018 | 99 | 0.140 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 359 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2023 | 630 | 0.140 |
Why?
|
| Syndrome | 1 | 2018 | 449 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 107 | 0.140 |
Why?
|
| Universities | 1 | 2018 | 148 | 0.140 |
Why?
|
| Intestinal Obstruction | 1 | 2017 | 91 | 0.130 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2016 | 18 | 0.130 |
Why?
|
| DNA Modification Methylases | 1 | 2016 | 29 | 0.130 |
Why?
|
| Epigenesis, Genetic | 2 | 2012 | 538 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 864 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 871 | 0.130 |
Why?
|
| DNA Repair Enzymes | 1 | 2016 | 57 | 0.130 |
Why?
|
| Environmental Monitoring | 2 | 2021 | 82 | 0.130 |
Why?
|
| Chlorpyrifos | 2 | 2007 | 4 | 0.130 |
Why?
|
| Cytokines | 1 | 2020 | 843 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 399 | 0.120 |
Why?
|
| Retrospective Studies | 4 | 2019 | 9689 | 0.120 |
Why?
|
| Carcinogens, Environmental | 1 | 2015 | 7 | 0.120 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 349 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 34 | 0.120 |
Why?
|
| Publications | 1 | 2015 | 27 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 294 | 0.110 |
Why?
|
| Colonic Neoplasms | 3 | 2009 | 581 | 0.110 |
Why?
|
| Sunburn | 1 | 2014 | 8 | 0.110 |
Why?
|
| Louisiana | 1 | 2014 | 18 | 0.110 |
Why?
|
| Heat Stress Disorders | 1 | 2014 | 12 | 0.110 |
Why?
|
| Disaster Planning | 1 | 2014 | 24 | 0.110 |
Why?
|
| Time Factors | 2 | 2021 | 5429 | 0.110 |
Why?
|
| Fungi | 1 | 2014 | 67 | 0.110 |
Why?
|
| Exanthema | 1 | 2014 | 41 | 0.110 |
Why?
|
| Adolescent | 2 | 2024 | 9495 | 0.100 |
Why?
|
| Sleep Deprivation | 1 | 2014 | 138 | 0.100 |
Why?
|
| Decision Making | 1 | 2018 | 680 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 2035 | 0.100 |
Why?
|
| Oman | 1 | 2011 | 5 | 0.090 |
Why?
|
| Arabs | 1 | 2011 | 16 | 0.090 |
Why?
|
| Cdh1 Proteins | 1 | 2010 | 2 | 0.090 |
Why?
|
| Biomarkers | 1 | 2017 | 1847 | 0.090 |
Why?
|
| Sulfites | 1 | 2010 | 31 | 0.090 |
Why?
|
| Leukocytes | 1 | 2011 | 212 | 0.080 |
Why?
|
| SEER Program | 2 | 2009 | 229 | 0.080 |
Why?
|
| Cardia | 1 | 2009 | 5 | 0.080 |
Why?
|
| Nicotinic Acids | 1 | 2009 | 8 | 0.080 |
Why?
|
| Child | 1 | 2020 | 7309 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2010 | 97 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 923 | 0.080 |
Why?
|
| Life Style | 2 | 2008 | 176 | 0.080 |
Why?
|
| Greenland | 1 | 2008 | 6 | 0.070 |
Why?
|
| Captan | 1 | 2008 | 1 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1117 | 0.070 |
Why?
|
| Cause of Death | 1 | 2009 | 270 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 404 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2007 | 6920 | 0.070 |
Why?
|
| Nitriles | 1 | 2008 | 158 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 547 | 0.070 |
Why?
|
| Connecticut | 2 | 2004 | 26 | 0.070 |
Why?
|
| Nitrates | 1 | 2007 | 36 | 0.070 |
Why?
|
| Water Supply | 1 | 2007 | 62 | 0.070 |
Why?
|
| Health Status | 1 | 2009 | 375 | 0.070 |
Why?
|
| Dicamba | 1 | 2006 | 1 | 0.070 |
Why?
|
| Brain | 1 | 2017 | 2355 | 0.060 |
Why?
|
| Disease Progression | 1 | 2010 | 1505 | 0.060 |
Why?
|
| Montana | 1 | 2006 | 9 | 0.060 |
Why?
|
| North Dakota | 1 | 2006 | 10 | 0.060 |
Why?
|
| South Dakota | 1 | 2006 | 47 | 0.060 |
Why?
|
| Minnesota | 1 | 2006 | 48 | 0.060 |
Why?
|
| Triazines | 1 | 2006 | 55 | 0.060 |
Why?
|
| Carcinoma | 1 | 2009 | 438 | 0.060 |
Why?
|
| Aniline Compounds | 1 | 2006 | 61 | 0.060 |
Why?
|
| Hematologic Neoplasms | 2 | 2006 | 355 | 0.060 |
Why?
|
| Chromatography, Gas | 1 | 2005 | 28 | 0.060 |
Why?
|
| Buttocks | 1 | 2005 | 10 | 0.060 |
Why?
|
| Parity | 1 | 2005 | 97 | 0.060 |
Why?
|
| Menopause | 1 | 2005 | 85 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2004 | 6 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 374 | 0.060 |
Why?
|
| India | 1 | 2005 | 128 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3514 | 0.060 |
Why?
|
| Glycine | 1 | 2005 | 95 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2005 | 234 | 0.050 |
Why?
|
| Mouth Neoplasms | 1 | 2006 | 199 | 0.050 |
Why?
|
| Research Design | 2 | 2004 | 600 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2007 | 343 | 0.050 |
Why?
|
| Breast | 1 | 2005 | 289 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 695 | 0.050 |
Why?
|
| Fatigue | 1 | 2024 | 177 | 0.050 |
Why?
|
| Prognosis | 1 | 2010 | 3872 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 497 | 0.050 |
Why?
|
| Certification | 1 | 2023 | 65 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 68 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 530 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2005 | 902 | 0.050 |
Why?
|
| Turtles | 1 | 2021 | 15 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 55 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1805 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 302 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 827 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 460 | 0.040 |
Why?
|
| Empathy | 1 | 2022 | 153 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 286 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 342 | 0.040 |
Why?
|
| Vertebrates | 1 | 2021 | 107 | 0.040 |
Why?
|
| Fishes | 1 | 2021 | 141 | 0.040 |
Why?
|
| Birds | 1 | 2021 | 169 | 0.040 |
Why?
|
| Pregnancy | 1 | 2005 | 3112 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 1575 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1024 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 145 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2010 | 74 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 405 | 0.020 |
Why?
|
| Nervous System Neoplasms | 1 | 2010 | 11 | 0.020 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2010 | 17 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2010 | 53 | 0.020 |
Why?
|
| Patients | 1 | 2010 | 107 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 379 | 0.020 |
Why?
|
| Nitroso Compounds | 1 | 2007 | 12 | 0.020 |
Why?
|
| Leukemia | 1 | 2010 | 324 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 268 | 0.020 |
Why?
|
| Amines | 1 | 2007 | 30 | 0.020 |
Why?
|
| Food Contamination | 1 | 2007 | 34 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 81 | 0.020 |
Why?
|
| Employment | 1 | 2007 | 53 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 173 | 0.020 |
Why?
|
| Poland | 1 | 2007 | 18 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 17 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2007 | 27 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1094 | 0.020 |
Why?
|
| Water | 1 | 2007 | 292 | 0.020 |
Why?
|
| Accidents, Occupational | 1 | 2005 | 8 | 0.010 |
Why?
|
| Spouses | 1 | 2005 | 31 | 0.010 |
Why?
|
| Lymphoma | 1 | 2006 | 268 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 609 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 351 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 267 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 28053 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 741 | 0.010 |
Why?
|